PB
Panbela Therapeutics, Inc.
PBLA · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $485.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 214.06%
Asset turnover 0.00x
ROIC 10,520.50%
Debt
57 /100
Moderate Int. coverage 81.28x
Current ratio 0.25x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 233.84%
Profitable years 0
Beta 1.88x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PBLA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer K. Simpson
Employees
8
Headquarters
Waconia
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report